Ghayth Hammad, MD PSC
Ghayth Hammad, MD PSC was paid $292K by Medicaid between Dec 2018 and Dec 2024, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 72% of everything it billed.
33Billing provider infoGHAYTH HAMMAD, MD PSC
MORGANTOWN, KY 42261
MORGANTOWN, KY 42261
33aNPI1366647075assigned 06/20/2007
33bProvider typeSpecialist
28Total paid$292K
24GClaims52,235
24DCodes billed71
24AFirst – last monthDec 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Kentucky
Rank by total paid#24 of 73
Median peer was paid$107K
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25 | $42.63 | |
| 2019 | 3,540 | $19K | |
| 2020 | 2,469 | $9K | |
| 2021 | 6,946 | $16K | |
| 2022 | 17,886 | $105K | |
| 2023 | 16,638 | $112K | |
| 2024incomplete | 4,731 | $31K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 72% | 13,270 | 10,221 | $209K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.8% | 1,573 | 1,286 | $14K |
| 99238 | Hospital discharge day management, 30 minutes or less | 3.8% | 816 | 698 | $11K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.1% | 1,968 | 658 | $9K |
| 71046 | Radiologic examination, chest; 2 views | 2.4% | 682 | 578 | $7K |
| 99497 | 2.3% | 455 | 417 | $7K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.0% | 432 | 387 | $6K |
| 99223 | Prolong inpt eval add15 m | 1.8% | 338 | 271 | $5K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.7% | 210 | 186 | $5K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1.4% | 264 | 230 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 419 | 189 | $4K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 43 | 41 | $3K |
59 more codes
| 99442 | <1% | 249 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 679 | $2K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 29 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 129 | $1K |
| 99406 | <1% | 277 | $1K | |
| 80305 | <1% | 114 | $546.96 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 18 | $307.86 |
| 90686 | <1% | 35 | $257.25 | |
| 99307 | <1% | 2,134 | $178.99 | |
| 93000 | <1% | 47 | $174.32 | |
| 90674 | <1% | 95 | $148.10 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 480 | $120.59 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 30 | $118.67 |
| 82962 | <1% | 295 | $103.25 | |
| 90756 | <1% | 20 | $45.58 | |
| G0008 | Administration of influenza virus vaccine | <1% | 119 | $45.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 27 | $22.79 |
| 81002 | <1% | 26 | $14.10 | |
| 3078F | <1% | 3,384 | $8.97 | |
| 1125F | <1% | 3,479 | $7.06 | |
| 3074F | <1% | 2,377 | $6.15 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 16 | $3.14 |
| 1159F | <1% | 4,024 | $3.09 | |
| 1160F | <1% | 4,047 | $3.08 | |
| 1126F | <1% | 1,095 | $2.56 | |
| 1101F | <1% | 3,900 | $2.35 | |
| 3066F | <1% | 654 | $1.04 | |
| 3075F | <1% | 200 | $0.63 | |
| 3044F | <1% | 29 | $0.14 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 36 | $0.07 |
| 4040F | 0% | 38 | $0.00 | |
| G8937 | Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given | 0% | 15 | $0.00 |
| G8935 | Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy | 0% | 15 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 29 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 30 | $0.00 |
| 3288F | 0% | 35 | $0.00 | |
| 3046F | 0% | 17 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 35 | $0.00 |
| 1100F | 0% | 35 | $0.00 | |
| G9665 | Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy | 0% | 13 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 28 | $0.00 |
| G9509 | Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5 | 0% | 29 | $0.00 |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 31 | $0.00 |
| 2022F | 0% | 36 | $0.00 | |
| 0518F | 0% | 34 | $0.00 | |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 1,632 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 165 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 509 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 245 | $0.00 |
| 1036F | 0% | 48 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 31 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 242 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 308 | $0.00 |
| 3017F | 0% | 37 | $0.00 | |
| G8450 | Beta-blocker therapy prescribed | 0% | 18 | $0.00 |
| 3079F | 0% | 13 | $0.00 | |
| 93922 | 0% | 17 | $0.00 | |
| 3061F | 0% | 14 | $0.00 | |
| G8452 | Beta-blocker therapy not prescribed | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAMMAD, GHAYTH (PRESIDENT)